Authors

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.

Omalizumab: An All-in-One Allergy Wonder Drug?

Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.

Just Culture Meets AI: How Pharmacists Are Leading Safer Transitions of Care

Enhancing PrEP Utilization Among Transgender Women: A Crucial Role for Pharmacists

Pharmacists can bridge gaps through education, inclusive care, and streamlined access.

Impact of Time to First Epinephrine Administration on Outcomes After In-Hospital Cardiac Arrest With Initial Nonshockable Rhythm

This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.

McKesson ideaShare 2025: Pharmacy of the Year Finalist Keri Bates Reflects on Teamwork, Community, and the Road Ahead

Keri Bates, PharmD, shares how the nomination validates years of hard work, highlights the deep relationships built with the community, and inspires continued growth and innovation.

Epcoritamab Plus Lenalidomide and Rituximab in Practice: A Focus on EPCORE FL-1

EPCORE trials show epcoritamab plus lenalidomide and rituximab delivers responses in relapsed refractory follicular lymphoma with outpatient dosing.

Improving Inpatient REMS Documentation Compliance With a Wildcard Checkpoint

Using wildcard hard-stop pharmacy preparation instructions in the electronic health record system significantly improved REMs documentation compliance at our institution.

Respecting Patient Curiosity in the Age of AI: How Oncology Teams Can Respond to Unproven Cancer Therapies

Oncology teams can address AI-driven cancer cures with empathy, evidence, and safer next steps to protect patients and trust.

Bridging the Gap: Field Teams and Hubs Supporting Patient Care

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

Study Highlights Filgrastim Savings Potential With Biosimilars

OTC Case Studies: Self-Care for Flu

Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications

GLP-1 receptor agonists expand treatment options for diabetes, weight loss, and more, showing promise in heart failure, kidney disease, and neuroprotection.

Kratom Controversies: Exploring Use and Regulation

Understand the Inextricable Link Between the Pharmacy Revenue Cycle and 340B

By aligning the pharmacy revenue cycle with the 340B Drug Pricing Program, organizations can maximize revenue capture from medications while ensuring compliance with 340B requirements, leading to enhanced financial performance and improved care for underserved populations.

Zuranolone Offers New Hope for Postpartum Depression

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

SGLT2 Inhibitors Did Not Appear to Alter Risk of Parkinson Disease Onset

The data, which were presented at the AAN 2026 Annual Meeting, support the agents’ neurological safety, but longer follow-ups and dedicated outcome trials are needed to confirm these findings.

Overcoming Failure as a Recent Pharmacy Graduate

Failing is not final, and it does not define what kind of pharmacist or resident a student can be.

Pharmacists and Providers: Key Collaborators in the Shift Toward Decentralized and Virtual Health Care

Virtual health care enhances patient experiences, integrates complex data, and ensures medication access through provider-pharmacist collaboration.

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.

In Mississippi’s Maternal Health Crisis, Pharmacies Become Lifelines

The Medications Optimizing Maternal Safety (MOMS) program offers vital support to pregnant patients through community pharmacies.

The Role of the Pharmacist in the Management of Psychosis in Parkinson Disease

Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.

Application of the Age-Friendly 4M’s Movement Across Different Areas of Pharmacy

Op-Ed: Cannabis Policy Needs Pharmacists

Canada’s experience demonstrates the risks of sidelining pharmacy in medical cannabis policy.

Reduced POMP Dosing Shows Comparable Efficacy in ALL Maintenance

Arefa Bacchus, PharmD, shared key insights about the use of POMP therapy in patients with acute lymphoblastic leukemia (ALL).

Combination Therapies and Resistance-Based Approaches Reshape EGFR Care

Mya Tran, PharmD, BCOP, offers insights for navigating the complex treatment landscape for non-small cell lung cancer.

Opinion: To Succeed, Direct-to-Patient Drug Sales Will Require Better Technology

Sibeprenlimab-szsi for Primary IgA Nephropathy: A New Drug Review

Sibeprenlimab, a new APRIL blocker, cuts proteinuria in IgA nephropathy.

What the Metrics Don't Measure

Pharmacists quietly prevent medication harm, ease discharge chaos, and manage rising health care strain through unseen cognitive work.